Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. National Cancer Institute - Nagpur

Verified

Basic Information

Site Overview

Source: Human-provided.

National Cancer Institute, Nagpur is a quaternary-care comprehensive oncology centre located in Jamtha, Nagpur, established under the Dr. Aabaji Thatte Sewa Aur Anusandhan Sanstha with the aim of delivering integrated cancer treatment, research, and patient care through sustainable charitable services. Spread across a 25-acre campus, the institute is planned as a state-of-the-art 470-bedded facility (expandable to 700 beds) offering advanced diagnostic, therapeutic, and supportive oncology services supported by modern infrastructure and multidisciplinary teams. The centre emphasises predictive, precise, preventive, personalised, and participatory cancer care, incorporating molecular diagnostics, genomics, advanced imaging, minimally invasive surgery, targeted therapies, and tumour board-based treatment planning. Alongside clinical services, it actively promotes clinical and epidemiological research, early detection programmes, community outreach, education, and collaborative…

Source: Trial-derived.
4Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
2Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
7Unique Conditions
Source: Trial-derived.
2Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Advanced Non-Small Cell Lung Cancer (2)Source: Trial-derived. Metastatic Non Small Cell Lung Cancer (2)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (1)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (NSCLC) (1)Source: Trial-derived. Lung Cancer (1)Source: Trial-derived. Metastatic Breast Cancer (1)Source: Trial-derived. Non-Small Cell Lung Cancer (1)

Sponsors

Source: Trial-derived. Pfizer (3)Source: Trial-derived. Hoffmann-La Roche (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Parking Options

Source: Google. On-site parking

Amenities

Amenities Available

Source: Google. Restroom
Source: Google. Gender-neutral restroom